Medical specialists from Canada tagged as investigators in clinical trials studying Ovarian Epithelial Cancer
Total 41 results
-
Amit M. Oza, MDSeen in:
- Ontario, Toronto, Princess Margaret Cancer Centre
Trials:- NCT05358639 (Sub-Investigator)
-
Amit OzaSeen in:
- Ontario, Toronto, Princess Margaret
- Ontario, Toronto, Princess Margaret Cancer Centre
- Ontario, Toronto, Princess Margaret Cancer Centre - University Health Network
- Ontario, Toronto, Princess Margaret Hospital
- Ontario, Toronto, University Health Network - Princess Margaret Hospital
- Ontario, Toronto, University Health Network, Princess Margaret Hospital
- Ontario, Toronto, University health Network (UHN)-University of Toronto
- Toronto, Princess Margaret Cancer Center
- Toronto, Princess Margaret Cancer Centre
Trials:- NCT05483933 (Principal Investigator)
- NCT04260802 (Principal Investigator)
- NCT05041257 (Principal Investigator)
- NCT05611931 (Principal Investigator)
- NCT02632448 (Principal Investigator)
- NCT04625270 (Principal Investigator)
- NCT05445778 (Principal Investigator)
- NCT05229900 (Principal Investigator)
- NCT04159155 (Principal Investigator)
- NCT02334761 (Principal Investigator)
- NCT05870748 (Principal Investigator)
- NCT06003231 (Principal Investigator)
Conditions:- Ovarian Cancer;
- Fallopian Tube Cancer;
- Epithelial Ovarian Cancer;
- Platinum-resistant Ovarian Cancer;
- Primary Peritoneal Carcinoma;
- Platinum-Resistant Fallopian Tube Carcinoma;
- Platinum-Resistant Primary Peritoneal Carcinoma;
- Sarcoma;
- Neoplasms;
- Renal Cell Carcinoma;
- Cervical Cancer;
- Cancer;
- Hepatocellular Carcinoma;
- Gastric Cancer;
- Non Small Cell Lung Cancer;
- Metastatic Cancer;
- Squamous Cell Carcinoma of Head and Neck;
- Bladder Cancer;
- Triple Negative Breast Cancer;
- Urothelial Carcinoma;
- Merkel Cell Carcinoma;
- Squamous Cell Carcinoma;
- Locally Advanced Malignant Neoplasm;
- Locally Advanced Solid Tumor;
- Urothelial Neoplasm;
- Peritoneal Cancer;
- Endometrial Cancer;
- Soft Tissue Sarcoma;
- Breast Cancer;
- Colorectal Cancer;
- Pancreatic Cancer;
- Rectal Cancer;
- Colon Cancer;
- Solid Tumors;
- Pancreas Cancer;
- Low Grade Ovarian Serous Adenocarcinoma;
- Uterine Cervical Neoplasms;
- Stomach Neoplasms;
- Testicular Neoplasms;
- Carcinoma, Non-Small-Cell Lung;
- Ovarian Neoplasms;
- Endometrial Neoplasms;
- Gastroesophageal Junction Carcinoma;
- Endometrial Carcinoma;
- P53 Mutation;
- Serous Carcinoma;
- Pathology;
- Primary Peritoneal Cancer;
- Carcinoma, Squamous Cell of Head and Neck
-
Anna TinkerSeen in:
- British Columbia, Vancouver, BC Cancer - Vancouver
- British Columbia, Vancouver, BC Cancer Vancouver
Trials:- NCT05456685 (Principal Investigator)
- NCT04787289 (Principal Investigator)
-
Annick Pina, MDSeen in:
- Quebec, Montreal, CHUM
Trials:- NCT05358639 (Sub-Investigator)
-
Beatrice Cormier, MDSeen in:
- Quebec, Montreal, CHUM
Trials:- NCT05358639 (Sub-Investigator)
-
Brent JimSeen in:
- Saskatchewan, Regina, Allan Blair Cancer Centre
Trials:- NCT04095364 (Principal Investigator)
Conditions:- Stage III Fallopian Tube Cancer AJCC v8;
- Stage III Ovarian Cancer AJCC v8;
- Stage III Primary Peritoneal Cancer AJCC v8;
- Stage IV Fallopian Tube Cancer AJCC v8;
- Stage IV Ovarian Cancer AJCC v8;
- Stage IV Primary Peritoneal Cancer AJCC v8;
- Stage II Fallopian Tube Cancer AJCC v8;
- Stage II Ovarian Cancer AJCC v8;
- Stage II Primary Peritoneal Cancer AJCC v8;
- Low Grade Fallopian Tube Serous Adenocarcinoma;
- Ovarian Low Grade Serous Adenocarcinoma;
- Primary Peritoneal Low Grade Serous Adenocarcinoma
-
Diane M. ProvencherSeen in:
- Quebec, Montreal, CHUM - Centre Hospitalier de l'Universite de Montreal
Trials:- NCT04095364 (Principal Investigator)
Conditions:- Stage III Fallopian Tube Cancer AJCC v8;
- Stage III Ovarian Cancer AJCC v8;
- Stage III Primary Peritoneal Cancer AJCC v8;
- Stage IV Fallopian Tube Cancer AJCC v8;
- Stage IV Ovarian Cancer AJCC v8;
- Stage IV Primary Peritoneal Cancer AJCC v8;
- Stage II Fallopian Tube Cancer AJCC v8;
- Stage II Ovarian Cancer AJCC v8;
- Stage II Primary Peritoneal Cancer AJCC v8;
- Low Grade Fallopian Tube Serous Adenocarcinoma;
- Ovarian Low Grade Serous Adenocarcinoma;
- Primary Peritoneal Low Grade Serous Adenocarcinoma
-
Diane ProvencherSeen in:
- Montréal, CHUM
- Montréal, Centre de recherche di Centre Hospitalier de i'Universite de Montreal
- Quebec, Montreal, CHUM
- Quebec, Montreal, Centre Hospitalier de L'Universite de Montreal - Centre de Recherche
- Quebec, Montréal, CHUM - Centre Hospitalier de l'Universite de Montreal
- Quebec, Montréal, CHUM - University of Montreal Hospital Centre
- Quebec, Montréal, Centre Hospitalier de l'Universite de Montreal
- Quebec, Montréal, Centre hospitalier de l'Université de Montréal (CHUM)
- Quebec, Montréal, GSK Investigational Site
Trials:- NCT05456685 (Principal Investigator)
- NCT04260802 (Principal Investigator)
- NCT05329545 (Principal Investigator)
- NCT02632448 (Principal Investigator)
- NCT06431594 (Principal Investigator)
- NCT03393884 (Principal Investigator)
- NCT05358639 (Principal Investigator)
- NCT04625270 (Principal Investigator)
- NCT05445778 (Principal Investigator)
- NCT04706962 (Principal Investigator)
- NCT05243524 (Principal Investigator)
Conditions:- Fallopian Tube Cancer;
- Primary Peritoneal Cancer;
- High Grade Ovarian Cancer;
- Sarcoma;
- Neoplasms;
- Renal Cell Carcinoma;
- Cervical Cancer;
- Cancer;
- Hepatocellular Carcinoma;
- Gastric Cancer;
- Ovarian Cancer;
- Non Small Cell Lung Cancer;
- Metastatic Cancer;
- Squamous Cell Carcinoma of Head and Neck;
- Bladder Cancer;
- Triple Negative Breast Cancer;
- Urothelial Carcinoma;
- Merkel Cell Carcinoma;
- Squamous Cell Carcinoma;
- Locally Advanced Malignant Neoplasm;
- Locally Advanced Solid Tumor;
- Urothelial Neoplasm;
- High Grade Serous Ovarian Cancer;
- Soft Tissue Sarcoma;
- Breast Cancer;
- Colorectal Cancer;
- Pancreatic Cancer;
- Rectal Cancer;
- Endometrial Cancer;
- Colon Cancer;
- Solid Tumors;
- Pancreas Cancer;
- Epithelial Ovarian Cancer;
- High Grade Serous Carcinoma;
- Low Grade Ovarian Serous Adenocarcinoma;
- Peritoneal Cancer;
- Solid Tumor;
- Prostate Cancer;
- Small-cell Lung Cancer;
- Thyroid Cancer;
- Cutaneous Melanoma;
- TNBC - Triple-Negative Breast Cancer;
- Hormone Receptor-positive Breast Cancer;
- SORT1+ Cancers;
- Platinum-resistant Epithelial Ovarian Cancer
-
Dr. Allan Covens, MDSeen in:
- Ontario, Toronto, Sunnybrook Research Institute
Trials:- NCT05961124 (Principal Investigator)
-
Gita Bhat, MDSeen in:
- Ontario, Toronto, Princess Margaret Cancer Centre
Trials:- NCT05358639 (Sub-Investigator)
-
Helen MacKaySeen in:
- Ontario, Toronto, Odette Cancer Centre - Sunnybrook Hospital
- Ontario, Toronto, Sunnybrook Health Sciences Centre
- Ontario, Toronto, Sunnybrook Research Institute/Odette Cancer Centre
- Toronto, Sunnybrook Hospital
Trials:- NCT03278717 (Principal Investigator)
- NCT02355171 (Principal Investigator)
- NCT05358639 (Principal Investigator)
- NCT03419689 (Principal Investigator)
-
Husam Ali Mahmoud Alqaisi, MDSeen in:
- Ontario, Toronto, Princess Margaret Cancer Centre
Trials:- NCT05358639 (Sub-Investigator)
-
Jennifer RauwSeen in:
- Victoria, BC Cancer Victoria
Trials:- NCT03278717 (Principal Investigator)
Conditions: -
Jenny Ko, MDSeen in:
- British Columbia, Abbotsford, Abbotsford Centre, BC Cancer Agency
Trials:- NCT04787289 (Principal Investigator)
Conditions: -
Katarzyna Jerzak, MDSeen in:
- Ontario, Toronto, Sunnybrook Research Institute/Odette Cancer Centre
Trials:- NCT05358639 (Sub-Investigator)
-
Lilian Gien, MDSeen in:
- Ontario, Toronto, Sunnybrook Research Institute/Odette Cancer Centre
Trials:- NCT05358639 (Sub-Investigator)
-
Lilian T. GienSeen in:
- Ontario, Toronto, Odette Cancer Centre- Sunnybrook Health Sciences Centre
Trials:- NCT04095364 (Principal Investigator)
Conditions:- Stage III Fallopian Tube Cancer AJCC v8;
- Stage III Ovarian Cancer AJCC v8;
- Stage III Primary Peritoneal Cancer AJCC v8;
- Stage IV Fallopian Tube Cancer AJCC v8;
- Stage IV Ovarian Cancer AJCC v8;
- Stage IV Primary Peritoneal Cancer AJCC v8;
- Stage II Fallopian Tube Cancer AJCC v8;
- Stage II Ovarian Cancer AJCC v8;
- Stage II Primary Peritoneal Cancer AJCC v8;
- Low Grade Fallopian Tube Serous Adenocarcinoma;
- Ovarian Low Grade Serous Adenocarcinoma;
- Primary Peritoneal Low Grade Serous Adenocarcinoma
-
Lucy GilbertSeen in:
- Quebec, Montreal, McGill University Department of Oncology / McGill University Health Centre
- Quebec, Montreal, McGill University Health Centre
- Quebec, Montreal, McGill University Health Centre, Royal Victoria Hospital
- Quebec, Montreal, Queen Elizabeth Health Centre
- Quebec, Montréal, McGill University Health Care
- Quebec, Montréal, McGill University Health Centere (MUHC)-Glen Site
- Quebec, Montréal, McGill University Health Centre
- Quebec, Montréal, McGill University Health Centre (MUHC)
Trials:- NCT05456685 (Principal Investigator)
- NCT05611931 (Principal Investigator)
- NCT02632448 (Principal Investigator)
- NCT06003231 (Principal Investigator)
- NCT05483933 (Principal Investigator)
- NCT05445778 (Principal Investigator)
- NCT05870748 (Principal Investigator)
- NCT02296307 (Principal Investigator)
- NCT04891029 (Principal Investigator)
Conditions:- Fallopian Tube Cancer;
- Primary Peritoneal Cancer;
- High Grade Ovarian Cancer;
- Endometrial Cancer;
- Neoplasms;
- Soft Tissue Sarcoma;
- Breast Cancer;
- Colorectal Cancer;
- Pancreatic Cancer;
- Ovarian Cancer;
- Rectal Cancer;
- Triple Negative Breast Cancer;
- Colon Cancer;
- Solid Tumors;
- Pancreas Cancer;
- Carcinoma, Non-Small-Cell Lung;
- Ovarian Neoplasms;
- Endometrial Neoplasms;
- Carcinoma, Squamous Cell of Head and Neck;
- Epithelial Ovarian Cancer;
- Platinum-resistant Ovarian Cancer;
- Primary Peritoneal Carcinoma;
- Platinum-Resistant Fallopian Tube Carcinoma;
- Platinum-Resistant Primary Peritoneal Carcinoma;
- Peritoneal Cancer;
- Diagnoses Disease
-
Neesha Dhani, MDSeen in:
- Ontario, Toronto, Princess Margaret Cancer Centre
- Ontario, Toronto, University Health Network (Princess Margaret Cancer Center)
- Other, Toronto, University Health Network, Princess Margaret Hospital
Trials:- NCT05358639 (Sub-Investigator)
- NCT05601752 (Principal Investigator)
- NCT04665921 (Principal Investigator)
- NCT04084951 (Principal Investigator)
Conditions:- Ovarian Cancer;
- Triple Negative Breast Cancer;
- High Grade Serous Carcinoma;
- Uterine Cervical Neoplasms;
- Stomach Neoplasms;
- Colorectal Neoplasms;
- Esophageal Neoplasms;
- Ovarian Neoplasms;
- Endometrial Neoplasms;
- Pseudomyxoma Peritonei;
- Carcinoma, Non-Small Cell Lung;
- Gastroesophageal Junction Carcinoma;
- HER2 Negative Breast Neoplasms;
- Exocrine Pancreatic Adenocarcinoma;
- Appendiceal Adenocarcinoma;
- Adult Solid Tumor
-
Omar Moreira-Basha, MDSeen in:
- Quebec, Montreal, CHUM
Trials:- NCT05358639 (Sub-Investigator)
-
Paul BessetteSeen in:
- Quebec, Sherbrooke, Ciussse-Chus
- Sherbrooke, Quebec, Sherbrooke University Hospital Centre
Trials:- NCT05456685 (Principal Investigator)
- NCT05041257 (Principal Investigator)
- NCT05329545 (Principal Investigator)
-
Philippe L. BedardSeen in:
- Ontario, Toronto, University Health Network-Princess Margaret Hospital
Trials:- NCT04317105 (Principal Investigator)
- NCT04491942 (Principal Investigator)
Conditions:- Advanced Malignant Solid Neoplasm;
- Unresectable Malignant Solid Neoplasm;
- Metastatic Malignant Solid Neoplasm;
- Anatomic Stage III Breast Cancer AJCC v8;
- Anatomic Stage IV Breast Cancer AJCC v8;
- Stage III Lung Cancer AJCC v8;
- Stage IV Lung Cancer AJCC v8;
- Clinical Stage III Gastric Cancer AJCC v8;
- Clinical Stage IV Gastric Cancer AJCC v8;
- Triple-Negative Breast Carcinoma;
- Stage IV Penile Cancer AJCC v8;
- Advanced Gastric Carcinoma;
- Advanced Breast Carcinoma;
- Stage III Cervical Cancer AJCC v8;
- Stage IV Cervical Cancer AJCC v8;
- Advanced Lung Non-Small Cell Carcinoma;
- Stage III Ovarian Cancer AJCC v8;
- Stage IV Ovarian Cancer AJCC v8;
- Advanced Ovarian Carcinoma;
- Unresectable Urothelial Carcinoma;
- Advanced Head and Neck Carcinoma;
- Advanced Lung Small Cell Carcinoma;
- Advanced Urothelial Carcinoma;
- Stage IV Distal Bile Duct Cancer AJCC v8;
- Stage IV Intrahepatic Bile Duct Cancer AJCC v8;
- Advanced Esophageal Carcinoma;
- Advanced Endometrial Carcinoma;
- Advanced Pleural Malignant Mesothelioma;
- Stage III Distal Bile Duct Cancer AJCC v8;
- Advanced Bile Duct Carcinoma;
- Advanced Cervical Carcinoma;
- Advanced Penile Carcinoma;
- Stage III Intrahepatic Bile Duct Cancer AJCC v8;
- Stage III Penile Cancer AJCC v8;
- Stage III Pleural Malignant Mesothelioma AJCC v8;
- Stage IV Pleural Malignant Mesothelioma AJCC v8
Clinical Trials on Ovarian Epithelial Cancer
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedCancer Survivor | Stage IIIA Ovarian Epithelial Cancer | Stage IIIB Ovarian Epithelial Cancer | Stage IIIC Ovarian Epithelial Cancer | Stage IIA Ovarian Epithelial Cancer | Stage IIB Ovarian Epithelial Cancer | Stage IIC Ovarian Epithelial Cancer | Stage IA Ovarian Epithelial Cancer | Stage IB Ovarian... and other conditionsUnited States
-
Centre Leon BerardCancer Côte d'or registry; Cancer Calvados registryUnknownOvarian Epithelial CancerFrance
-
National Cancer Institute (NCI)CompletedStage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial CancerUnited States
-
Life Research Technologies GmbHUnknownOvarian Epithelial CancerAustria, Hungary
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedFallopian Tube Cancer | Stage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity CancerCanada
-
National Cancer Institute (NCI)CompletedStage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnRecurrent Pancreatic Cancer | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage IV Ovarian Epithelial Cancer | Stage IV Ovarian Germ Cell Tumor | Recurrent Ovarian Epithelial Cancer | Recurrent Ovarian Germ Cell Tumor | Stage IIIA Ovarian Germ Cell Tumor | Stage IIIB Ovarian Germ Cell... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedStage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial CancerUnited States
-
National Cancer Institute (NCI)CompletedFallopian Tube Cancer | Stage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial CancerUnited States